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Abstract: The inﬂ  ammatory response is modulated through interactions among the nervous, endocrine, and immune 
systems. Intercommunication between immune cells and the autonomic nervous system is a growing area of interest. 
Spatial and temporal information about inﬂ  ammatory processes is relayed to the central nervous system (CNS) where 
neuroimmune modulation serves to control the extent and intensity of the inﬂ  ammation. Over the past few decades, 
research has revealed various routes by which the nervous system and the immune system communicate. The CNS 
regulates the immune system via hormonal and neuronal pathways, including the sympathetic and parasympathetic 
nerves. The immune system signals the CNS through cytokines that act both centrally and peripherally. This review 
aims to introduce the concept of neuroimmune interaction and discuss its potential clinical application, in an attempt 
to broaden the awareness of this rapidly evolving area and open up new avenues that may aid in the treatment of inﬂ  am-
matory diseases.
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Neural Regulation of the Immune System
The CNS regulates the immune system through hormonal and neuronal pathways. The Hypothalamic-
Pituitary-Adrenal (HPA) axis is the most important neuroendocrine pathway. Corticotropin releasing 
hormone (CRH) released from the paraventricular nucleus of the hypothalamus into the hypophyseal 
portal circulation causes the anterior pituitary gland to secrete adrenocorticotropin (ACTH). ACTH 
in turn induces the expression and release of glucocorticoids from the adrenal gland. Glucocorticoids 
suppress the immune system and have been used extensively in the treatment of inﬂ  ammatory diseases 
since the 1940s (Webster, Tonelli, and Sternberg, 2002). In addition to affecting immune cell traf-
ﬁ  cking, migration, maturation and differentiation, glucocorticoids regulate the expression of cytokines, 
adhesion molecules, and chemotactic factors (Eskandari, Webster, and Sternberg, 2003). Glucocor-
ticoids shift the cytokine pattern from pro-inﬂ  ammatory [interleukin-1 (IL-1) and tumor necrosis 
factor-alpha (TNF-α)] to anti-inﬂ  ammatory (IL-10) (Elenkov and Chrousos, 1999). Glucocorticoids 
act through a cytosolic glucocorticoid receptor that eventually translocates into the nucleus and binds 
to speciﬁ  c DNA sequences called glucocorticoid response elements to regulate gene transcription 
(Aranda and Pascual, 2001). Abnormalities in the signaling pathways can over-express or under-
express certain inﬂ  ammatory mediators, leading to diseases such as asthma (Leung et al. 1997), 
inﬂ  ammatory bowel disease (Honda et al. 2000), and rheumatoid arthritis (Derijk et al. 2001). Other 
Hypothalamic-Pituitary-target axes, such as the Hypothalamic-Pituitary-Gonadal axis, have also been 
implicated in the immune response (Berczi, 2001). At physiological concentrations, estrogen enhances 
the immune response whereas androgens suppress it (Cutolo and Wilder, 2000). For this reason, 
autoimmune and inﬂ  ammatory diseases are more common in females than in males (Olsen and 
Kovacs, 1996).
Dendritic cells are antigen presenting cells. Their bone marrow-derived precursors reach most 
tissue via the bloodstream, becoming resident immature dendritic cells. These cells mature after 
activation and initiate the immune responses toward foreign proteins (Caux, Liu, and Banchereau, 
1995). After capturing antigens, dendritic cells migrate to the T cell-dependent lymphoid organs via 
the afferent lymph. Their migration depends on the cell maturation and on the concentration of 
neuropeptides released by the sensory neurons at the site of inﬂ  ammation (Dunzendorfer et al. 2001). 36
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Thus, stimulation of sensory nerve during 
inﬂ  ammation may recruit antigen presenting cells 
to the inﬂ  ammatory sites and therefore, propagate 
and control the degree of response.
Neural control of the immune system also 
occurs through the sympathetic and parasympa-
thetic nerves. Both, in general, are anti-
inﬂ  ammatory. The sympathetic nerve innervates 
immune organs, such as the thymus, spleen and 
lymph nodes, causing effects through release of 
catecholamines. Immune cells (CD4+ T cells and 
B cells) express β2 adrenergic receptors, support-
ing direct regulation by neurotransmitters released 
from sympathetic efferents (Kin and Sanders, 
2006). Catecholamines decrease pro-inﬂ  ammatory 
cytokines, stimulate anti-inﬂ  ammatory cytokines, 
and favor a shift from Th1 (cellular) to Th2 
(humoral) responses (Elenkov and Chrousos, 
1999). The parasympathetic nerves innervate most 
visceral organs and regulate the immune response 
through the so called ‘inﬂ  ammatory reﬂ  ex’ by a 
vagal-vagal mechanism (Tracey, 2002). In this 
scenario, vagal afferents are stimulated by pro-
inﬂ  ammatory cytokines (TNF-α and IL-1β) and 
mediators (histamine and prostaglandins) and 
reﬂ  exively activate vagal efferents, via the solitary 
nucleus, to release acetylcholine (Ach) (Fig. 1). 
Subsequently, Ach acts through alpha-nicotinic 
receptors on macrophages to  
inhibit production of pro-inﬂ  ammatory cytokines 
(Borovikova et al. 2000; Wang et al. 2003a). 
Stimulation of vagal afferents by intraperitoneal 
Figure 1. Illustration of a neuroimmune interaction. Inﬂ  ammatory mediators and cytokines may activate vagal afferents, causing a ‘reﬂ  ex’ 
via NTS to trigger neural circuitry and ﬁ  nally through vagal efferents to inhibit inﬂ  ammatory cells to release inﬂ  ammatory agents. The large, 
bold, blue arrows indicate initiation of the reﬂ  ex pathway, while the thin, blue arrows denote a direct stimulatory effect; the red arrow indicates 
an inhibitory effect. Involvement of inter-neurons is indicated by two-arrow connections. LPS and high levels of cytokines and mediators may 
inﬂ  uence the higher brain centers via the CVO. 
Abbreviations: Ach: Acytylcholine; CVO: Circumventricular Organ; Hypotha: hypothalamus; Inﬂ  am. cells: inﬂ  ammatory cells; NA: Nucleus 
Ambiguous; NTS: Nucleus Tractus Solitarus; LPS: Lipopolysacharide; VMN: Vagal Motor Nucleus.37
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injection of IL-1β produces sickness responses 
(fever, lethargy, etc.), which is blocked by 
sub-diaphragmatic vagotomy (Goehler et al. 
1999). Vagal afferent activity is also increased by 
exogenous IL-1β injected into the receptive ﬁ  eld 
of vagal sensory afferents in the lung (Yu et al. 
2007) or by abdominal injection of lipopolysac-
charides (LPS) that increase endogenous IL-1β. 
Electrical stimulation of vagal afferents increases 
IL-1β expression in the brain and activates HPA 
axis (Hosoi, Okuma, and Nomura, 2000). Electri-
cal stimulation of vagal efferents during lethal 
endotoxemia inhibits TNF synthesis in the liver 
and lowers its serum level, preventing endotox-
emic shock (Borovikova et al. 2000). Furthermore, 
using nicotine to activate the cholinergic anti-
inflammatory pathways reduces mortality of 
endotoxemia (Wang et al. 2004) and inhibits endo-
thelial cell activation and leukocyte migration 
(Saeed et al. 2005). Vagotomy nearly doubled 
mortality in septic animals (Kessler et al. 2006). 
Moreover, the discovery that mast cells interact 
with the nervous system through synaptic cell 
adhesion molecules (Ito and Oonuma, 2006) has 
shed light into the complex neuron-immune reac-
tion. This vast undiscovered area of physiology 
has sparked interest and coined the term “the 
neuro-immune system” of disease.
Inﬂ  uences of the Immune System 
on the CNS
The neuro-immune interaction is bidirectional 
through their soluble products: cytokines and 
mediators (Shepherd, Downing, and Miyan, 
2005). Inﬂ  ammatory cytokines play a crucial role 
in immune stimulation of nerves. Cytokines 
are a heterogenous group of polypeptides associ-
ated with activating the immune system and 
inﬂ  ammatory responses. Cytokine receptors are 
found throughout the nervous system, including 
the CNS, vagus nerve, dorsal root ganglia, sciatic 
and sural nerves (Goehler et al. 1997; Plata-
Salaman, 1991; Sorkin et al. 1997). IL-1β recep-
tors are found even in carotid bodies (Wang et al. 
2002). Activation of cytokine receptors contrib-
utes to neurological diseases such as multiple 
sclerosis, AIDS dementia complex, stroke, and 
Alzheimer’s disease (Benveniste, 1998; Hopkins 
and Rothwell, 1995; Rothwell and Hopkins, 
1995). During acute inflammatory states the 
immune response includes systemic release of 
IL-1, which acts on the brain to activate the HPA 
axis to modulate the inflammatory response 
(Haddad, Saade, and Saﬁ  eh-Garabedian, 2002).
Cytokines exert their effects on the CNS by 
various mechanisms, including: 1) by crossing 
the blood brain barrier through an active transport 
mechanism, 2) by passively diffusing through 
brain areas called circumventricular organs 
(CVO), where the fenestrated capillaries allow 
for higher permeability. Through the CVO, the 
brain can monitor levels of cytokines and medi-
ators in the blood, and 3) by directly activating 
peripheral sensory nerves (Hosoi, Okuma, and 
Nomura, 2002). Pro-inﬂ  ammatory cytokines or 
mediators may induce a series of mood and 
behavioral changes (collectively termed sickness 
behaviour, which is adaptive and helps the host 
to prevent system failure) by acting on receptors 
in the CNS, which are identical to those found 
on immune cells (Dantzer, 2004). The vagus 
nerve innervates a vast majority of internal 
organs, hence it can potentially receive various 
immune stimuli and convey immunological 
information to the CNS (Goehler et al. 1997; 
Watkins et al. 1995). In addition, fever develops 
within minutes following the peripheral injection 
of LPS when concentrations are not adequate to 
affect the brain in time to account for the response 
(Hosoi, Okuma, and Nomura, 2002; Kluger, 
1991). These observations support a neural path-
way that conveys peripheral immune signals to 
the brain and suggest a surveillance role of the 
CNS in numerous systemic diseases related to 
organ dysfunction like Irritable Bowel Syndrome 
and Acute Lung Injury.
In summary, the nervous system regulates the 
immune responses. Inflammation, a common 
mechanism involved in the pathophysiological 
process of various diseases, is an integral part of 
innate immune responses. Inﬂ  ammatory products 
activate sensory nerves and send signals regarding 
the state of the inﬂ  ammation to the CNS. Further-
more, through the reflex, efferent nerves can 
release mediators that act on immune cells (Fig. 1). 
In the following sections, we will discuss some 
particular inﬂ  ammatory diseases associated with 
neuroimmune interaction.
Rheumatology
Rheumatoid arthritis (RA) affects 1% of the gen-
eral population, making it the most common form 38
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of chronic inflammatory arthritis. RA can be 
divided into two main phases: pre-clinical and 
clinical. The pre-clinical phase is asymptomatic 
(Vassilopoulos and Mantzoukis, 2006), when auto-
antibodies can be detected in blood (Nielen et al. 
2004). Neuronendocrine interaction plays a crucial 
role at this stage. The clinical phase is symptom-
atic and can be further divided into early and 
chronic phases. Chronic inﬂ  ammation alters neu-
ropeptide processing, leading to long-term func-
tional and structural changes in innervation, 
neurovascular regulation, and immune modula-
tion. An altered HPA axis in RA points to an 
interaction between the disease and the neuroen-
docrine system.
The symmetric involvement of joints in RA and 
autonomic dysfunction associated with RA pro-
vides a compelling link of the disease with the 
CNS. Additionally, patients with central or periph-
eral hemiparesis who later develop RA, do not have 
joint disease in the paretic limbs, further suggest-
ing neuronal involvement. In Sprague Dawley rats, 
inﬂ  ammation (swelling and hyperalgesia) induced 
in one hindpaw produced the same signs in the 
contralateral paw with a similar magnitude and 
duration (Levine et al. 1985b). Chronic denerva-
tion of either the injured or the uninjured limb 
markedly attenuated the contralateral inﬂ  ammatory 
response. This suggests that local inﬂ  ammation 
can stimulate sensory nerves and reﬂ  exively pro-
duce inﬂ  ammatory responses in the contralateral 
limb. In addition, denervation by capsaicin in either 
hind limb attenuates the contralateral responses, 
indicating an involvement of afferent C-ﬁ  bers. Vein 
ligation has no effect on the inﬂ  ammatory responses 
observed, excluding the possibility of humoral 
mediation (Levine et al. 1985a).
In physiological states, synovial nociceptors 
(C ﬁ  bers and Aδ ﬁ  bers) remain silent. During 
inﬂ  ammation, however, they become sensitized 
to chemical, mechanical and thermal stimulation 
via two mechanisms. First, the mechanosensitive 
myelinated A ﬁ  bers mediate sensitization at the 
pre-synaptic (CNS) level through repeated, pro-
longed stimulation. Second, soluble cytokines 
and inﬂ  ammatory mediators (prostaglandins, 
adenosine, serotonin, and bradykinin) can 
directly sensitize neurons, including nociceptors 
(Niissalo et al. 2002). TNF-α and IL-1β play 
vital roles in joint inflammation and bone 
destruction. Immun-modulators such as steroids, 
anti-TNF, and anti-IL-1 have become the 
mainstay treatment in severe RA. The immune 
response is predominantly regional, but can be 
systemic. Substance-P (SP) released by sensory 
ﬁ  bers in the inﬂ  amed synovium, cytokines such 
as TNF-α and IL-2, and circulating activated 
immune cells have all been implicated in rheu-
matoid pathology (Straub and Cutolo, 2001). For 
example, SP, which is pro-inflammatory, is 
secreted by nerves and inﬂ  ammatory cells such 
as macrophages, eosinophils, lymphocytes and 
dendritic cells and acts through its neurokinin-1 
(NK-1) receptor. SP and NK-1 receptor mRNA 
levels are elevated in the synovium and syn-
oviocytes of patients with RA. Joint inﬂ  amma-
tion involves plasma extravasation, inﬁ  ltration 
of the synovium with inflammatory cells, 
followed by vascular remodeling. SP potentiates 
plasma extravasation and enhances inﬂ  ammatory 
responses in a mouse arthritis model (Keeble 
et al. 2005). Inﬂ  ammatory signals activate the 
HPA axis and the hypothalamic-autonomic ner-
vous system axis, exerting anti-inﬂ  ammatory 
effects in arthritic joints through cortisol and 
catecholamines. In theory, an inadequate neuro-
endocrine response may result in the transition 
from the early to chronic phase in RA. Sympa-
thetic responses are increased in RA patients 
following stimulation of sensory ﬁ  bers in syno-
vial tissue. Despite this, the number of sympa-
thetic ﬁ  bers in inﬂ  amed RA joints is lower than 
in non-inﬂ  ammatory joints (Miller et al. 2000). 
Perhaps this loss of sympathetic ﬁ  bers prevents 
the host from conveying anti-inflammatory 
actions through the sympathetic system.
Following exposure to streptococcal cell wall 
antigen, chronic arthritis develops in Lewis rats, 
which have a blunted HPA response, but not in 
Fischer rats having an increased hypothalamic 
CRH response. Glucocorticoid antagonists increase 
the susceptibility to arthritis, while glucocorticoids 
suppress the inﬂ  ammatory response in arthritic rats 
(Vassilopoulos and Mantzoukis, 2006). However, 
arthritis in rat models is a polygenic disease where 
the impact of genetic variability on phenotypic 
expression accounts for about one-third of the 
cases. In human RA, genetic analysis for disease 
susceptibility has been performed around the 
world. Human Leukocyte Antigen (HLA)-related 
genes may be involved in predisposition to disease 
in about one-third of the cases, whereas non-HLA 
regions are responsible for remainders (Steinsson 
and arcon-Riquelme, 2005). Newly developed gene 39
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identiﬁ  cation techniques may help determine if 
genes associated with the neuroendocrine axis play 
a role in RA predisposition.
The neuroendocrine link has also been implicated 
in Sjogren’s syndrome (Johnson and Moutsopoulos, 
2000), chronic fatigue syndrome and ﬁ  bromyalgia 
(Moldofsky, 1995). Sjogren’s syndrome is a perfect 
model for studying alterations in the neuroendocrine-
immune system, since patients are usually medica-
tion free and hence devoid of the confounding 
effects of immunosuppressive treatment (Johnson 
and Moutsopoulos, 2000).
Neurological Diseases
There has been much interest in the relationship 
between inﬂ  ammation and pain. Painful informa-
tion (nociception) is relayed to the CNS through 
afferent nerves, which are mostly comprised of 
unmyelinated C ﬁ  bers and myelinated Aδ ﬁ  bers. 
These afferents synapse to second order neurons in 
the dorsal horn of the spinal cord. Nociceptors are 
usually polymodal, responding to a variety of nox-
ious stimuli (Kidd and Urban, 2001). Tissue inﬂ  am-
mation or injury generates a surge of inﬂ  ammatory 
mediators (cations, bradykinin, histamine, 5 HT, 
ATP, nitric oxide and cytokines). These mediators 
can either directly stimulate or sensitize the noci-
ceptors. They can also increase production and 
release of more inﬂ  ammatory mediators, leading 
to nociceptor activation. Hence, pro-inﬂ  ammatory 
mediators may play a major role in the pathogen-
esis of chronic neuropathic pain syndromes.
Painful neuropathies are caused by nerve injury 
from inﬂ  ammatory disease or trauma, and are inﬂ  u-
enced by cytokines and immune mediators (Baron, 
2000). Their study can be traced back to Mitchell’s 
classic work from the American Civil War (Moalem 
and Tracey, 2006). Nerve injury activates resident 
immune cells and recruits inﬂ  ammatory cells to the 
injured sites, initiating an inﬂ  ammatory cascade. 
Mast cells near the nerve are activated to release 
histamine and TNF-α, which recruit neutrophils and 
macrophages, as well as sensitize nociceptors. In 
turn, the recruited inﬂ  ammatory cells secrete cyto-
kines and mediators (TNF-α and PGE2) that can 
further sensitize nociceptors. Nerve injury releases 
mediators, including ATP, nerve growth factor, PGE2 
and pro-inﬂ  ammatory cytokines. This promotes 
recruitment of T cells, secreting a variety of cyto-
kines. This cocktail of mediators enhances the 
inﬂ  ammation and contributes to pain (Moalem and 
Tracey, 2006). Focal neuritis in the rat sciatic nerve 
produces neuropathic pain sensations. Neuroim-
mune interaction occurs at the outset of nerve injury 
that produces neuropathic pain. For example, TNF-
α can be released from sciatic Schwann cells (Wag-
ner and Myers, 1996) and injection of TNF-α and 
IL-1β into rat sciatic nerve causes pain (Zelenka, 
Schafers, and Sommer, 2005). TNF-α can stimulate 
the sciatic nerve directly. Intradermal injection of 
TNF-α leads to sensitization and subsequent hyper-
algesia (Sorkin et al. 1997). Such an interaction may 
prime the system for slowly developing sustained 
pain during the chronic phase of neuropathy (Ben-
nett, 1999). Over time, episodic priming, by the 
release of inﬂ  ammatory mediators, may also con-
tribute to chronic conditions like diabetic neuropa-
thy. Guillain-Barré Syndrome, an autoimmune 
injury of the peripheral nervous system causing 
demyelination, is characterized by progressive 
ascending polyneuropathy, which may progress to 
quadriplegia and lead to respiratory arrest. A strong 
correlation of serum levels of TNF-α and its 
receptors with disease severity and recovery is 
found in patients with Guillain-Barré Syndrome 
(Radhakrishnan et al. 2003).
Sympathetic nerve has been investigated in 
various studies related to neuroimmune interac-
tion, including the pathogenesis of multiple scle-
rosis (Elenkov et al. 2000). Receptors for 
sympathetic neural transmitter, β2 adrenoceptors, 
provide important protective and supportive func-
tions in cell proliferation, response, and metabo-
lism. Astrocytes in multiple sclerosis lack β2 
adrenoceptors (De et al. 2004), the activation of 
which inhibits the expression of pro-inﬂ  ammatory 
cytokines via cAMP. Lack of β2 adrenoceptors 
may also transform astrocytes into facultative 
antigen presenting cells, initiating the inﬂ  amma-
tory cascade. β2 receptor defects also impair 
glycogenolysis, which generates lactate as an 
energy source for axons. Disturbances in axonal 
metabolism may cause accumulation of calcium 
ions inside the axon and thus degeneration. This 
rationale might provide a new therapeutic strategy 
to reduce or prevent both relapses and the progres-
sion of multiple sclerosis by increasing c-AMP 
levels in astrocytes (De et al. 2004).
Gastrointestinal Tract
Recent research demonstrates the interrelation-
ship between the nervous system and the 40
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mucosal immune system (Shanahan, 1999). In 
the gastrointestinal (GI) tract, activated mast 
cells release inflammatory mediators, which 
in turn stimulate sensory nerve endings (De 
Jonge et al. 2005). Activation of sensory nerves 
initiates ‘the inflammatory reflex’, releasing 
acetylcholine from vagal efferents and inhibit-
ing cytokine production by macrophages (De 
Jonge et al. 2005). Furthermore, vagotomy 
leads to increase levels of IL-6, TNF-α and 
IL-1β in the gut (Ghia et al. 2006), exemplify-
ing the vagal anti-inflammatory effects. Such 
a mechanism explains a well-established rela-
tionship between tobacco use (nicotine) and 
inflammatory bowel disease (IBD). In ulcer-
ative colitis, the protective effect of nicotine 
is related to the α7-subunit and its inhibition 
of TNF-α (Johnson, Cosnes, and Mansfield, 
2005) and IL-8 (Louvet et al. 1999). Bowel 
manipulation, transplantation, and ischemia/
reperfusion injury activate intestinal macro-
phages and cause acute gut inflammation. The 
pathogenesis of post-operative ileus exempli-
fies such a mechanism. Macrophages are acti-
vated in the muscularis externa of the human 
small bowel following intestinal manipulation 
(Kalff et al. 2003). Once activated, these resi-
dent macrophages release pro-inflammatory 
mediators that cause bowel inflammation and 
inhibit contractility. Local inflammation can 
also inhibit distant sites, demonstrating that a 
neural pathway can paralyze the entire GI tract 
(de Jonge et al. 2003).
Inflammatory bowel disease, including 
Crohn’s disease and ulcerative colitis, is charac-
terized by overproduction of inﬂ  ammatory cyto-
kines, dysregulation of mucosal immunity and 
uncontrolled inﬂ  ammation in the gut. In patients 
with IBD, structural abnormalities include enteric 
glial cell hyperplasia (Geboes and Collins, 1998), 
ganglion cell and axonal degeneration, and necro-
sis (Dvorak et al. 1993). Functionally, enteric 
glial cells are equivalent to astrocytes in the CNS 
(Cabarrocas, Savidge, and Liblau, 2003). Enteric 
glial cells and neurons in Crohn’s Disease express 
a major histocompatibility complex class 2 anti-
gen on their cell surface (similar to macrophages) 
allowing them to act as antigen presenting cells 
and release pro-inflammatory cytokines and 
mediators (Geboes et al. 1992). SP has been 
implicated in IBD pathology. In IBD mouse mod-
els, NK-1 receptors (the binding sites for SP) 
were up-regulated in intestinal tissue. NK-1 
receptor antagonists decreased disease severity 
and promoted healing pre-existing lesions (Sonea 
et al. 2002). Inﬂ  iximab, an antibody, which neu-
tralizes TNF-α and down-regulates interferon 
gamma production (Agnholt and Kaltoft, 2001), 
beneﬁ  ts patients with active steroid-dependent 
or with ﬁ  stulizing Crohn’s disease. All stated 
above are consistent with that neuroimmune 
interactions play a role in the pathogenesis of 
IBD. Perhaps new avenues will open up for 
designing drugs to modify the disease course and 
decrease the morbidity of IBD.
Irritable bowel syndrome (IBS) is the conse-
quence of altered visceral perception and regula-
tion of gastrointestinal motility and epithelial 
function, and is associated with CNS disturbance 
and psycosocial stresses (Barbara et al. 2004). 
The syndrome may accrue from primary altera-
tions in the periphery or in the CNS, or a com-
bination (Mayer, Naliboff, and Chang, 2001). 
Brain-gut interactions are mediated by outputs 
from the autonomic and neuroendocrine systems, 
as well as from attentional and pain modulatory 
responses. Psychological and physical stressors 
affect function of the GI tract through neuronal 
activity within emotion-speciﬁ  c circuits in the 
brain, and therefore enhancing gastric motility, 
mucosal blood flow and acid secretion. In 
response to internal or external stress, pro-inﬂ  am-
matory cytokines in the GI tract are increased. 
This causes perception of symptoms via intrinsic 
and extrinsic primary afferent neurons (Barbara 
et al. 2004), which in turn further activates the 
neuronal circuits, intensifying the symptoms. 
Thus, IBS patients have an enhanced GI respon-
siveness due to malfunction of the neuro-
endocrine-immune interaction (Mulak and 
Bonaz, 2004). In the last 20 years, low dose 
antidepressants have been successfully used to 
treat IBS patients, partly due to their neuro-
modulator properties, in addition to their anal-
gesic effects (Wald, 2002).
Lastly, neuroimmune interaction may also 
account for some cases of appendicitis that are 
negative for inflammation on histopathology. 
These are associated with neuroproliferation and 
increased SP and vasointestinal polypeptides. This 
distinct pathological entity, neuroimmune appen-
dicitis, explains up to 25% of normal appendixes 
in surgical patients (Di et al. 1999). In experimen-
tal pancreatitis, the vagus nerve provides a 41
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protective function through anti-inﬂ  ammatory 
effects via nicotinic receptors (van Westerloo et al. 
2006). This may result in new approaches to 
treating acute pancreatitis besides bowel rest and 
pain analgesia.
Respiratory System
Pulmonary nociceptors, the most abundant afferent 
nerves in the lung, are sensitive to inﬂ  ammatory 
products, such as histamine, prostaglandins, and 
SP (Coleridge and Coleridge, 1984; Lee and 
Pisarri, 2001). Rodent nociceptors are associated 
with neuropeptides, SP, tachykinins, and Calcitonin 
Gene-Related Peptide, as well as other neurokinins. 
These neuropeptides are responsible for neurogenic 
inﬂ  ammation through the interaction of nociceptive 
ﬁ  bers and alveolar macrophages, releasing neuro-
peptides and cytokines, respectively (McDonald, 
1987; Solway and Leff, 1991). TNF-α increases 
bronchial tissue responsiveness (Anticevich et al. 
1995), suggesting a role of inﬂ  ammatory cytokines 
in asthma and COPD. Accumulating evidence 
indicates the neuroendocrine and immune systems 
interact during the development of asthma (Mar-
shall, Jr. and Agarwal, 2000). Many mediators 
released in the inﬂ  ammatory zone may modulate 
sensory and motor nerves in the airways (Barnes, 
1992). Sensory nerves, in turn, may amplify 
inﬂ  ammation through the release of peptide neu-
rotransmitters. Electrical stimulation of the cervi-
cal vagus nerve evokes neurogenic inﬂ  ammation 
in the trachea and bronchi of rats. Neural mediators 
modulate the pulmonary inﬂ  ammatory response 
by triggering vasodilatation, tissue edema, and 
influx of inflammatory cells (Kraneveld and 
Nijkamp, 2001). SP and neurokinin are involved 
in bronchoconstriction and mucous production. 
The presence of SP in sensory ﬁ  bers is the ground-
work of neurogenic inﬂ  ammation. Interestingly, 
mechanosensors in the lung, which do not 
express SP, become SP immune reactive after 
allergen challenge in guinea pigs. Ipsilateral 
vagotomy suppresses the SP expression (Chuaychoo 
et al. 2005). Nerve growth factor, which is 
closely associated with asthma, is released 
from lung ﬁ  broblasts at an increased rate when 
exposed to TNF-α and IL-1β (Olgart and Frossard, 
2001). Pulmonary afferents, traveling through 
sympathetic nerves, also exist (Soukhova et al. 
2003; Wang et al. 2003b) and potentially contribute 
to lung pathophysiology. Acute hypoxia inﬂ  uences 
the neuroimmune system through the action of 
IL-1β under numerous conditions (asthma, chronic 
obstructive lung disease, sleep apnea and heart 
failure) (Johnson et al. 2007). In addition, emotions 
have a clear inﬂ  uence on asthmatic attack. A num-
ber of studies have found a relationship between 
asthma and negative emotions, such as anxiety, 
anger, and sadness (von, Ehnes, and Dahme, 2006), 
supporting a neuroimmune interaction.
Acute Respiratory Distress Syndrome (ARDS) 
is a major source of intensive care mortality 
because of its association with other acute disor-
ders (infection, trauma, sepsis, intoxication, or 
pancreatitis). Pro-inﬂ  ammatory cytokines may be 
crucial in the initiation, propagation, maintenance 
and regression of the inﬂ  ammatory response in 
the lungs by stimulating pulmonary nociceptors. 
Pro-inﬂ  ammatory cytokines are markedly elevated 
in broncho-alveolar lavage (BAL) samples from 
patients with ARDS, or those at risk for ARDS 
(Siler et al. 1989; Suter et al. 1992). TNFα, IL-1β 
and IL- 6 in plasma and BAL are increased in
 
non-survivors of ARDS (Meduri et al. 1995). 
Furthermore, pulmonary nociceptor activity is 
increased dramatically during oleic acid-induced 
ARDS (Lin et al. 2007) or by direct injection of 
the inﬂ  ammatory cytokine IL-1β into the sensory 
receptive ﬁ  eld (Yu et al. 2007). This supports 
neuroimmune interaction mechanisms during 
acute pulmonary events.
Conclusion
As a mechanism, neuroimmune interaction con-
trols inﬂ  ammation in multiple diseases. The con-
nection between the brain and inflammatory 
diseases is not restricted to the previous examples. 
Brain-skin interaction is increasingly recognized. 
For example, atopic dermatitis patients demon-
strate a blunted HPA axis response (Buske-
Kirschbaum et al. 2002). Neurokinins derived from 
sensory nerves interact with antigen presentation 
in dermal Langerhans cells in allergic skin disease 
(Darsow and Ring, 2001). Intracerebral adminis-
tion of melanocyte-stimulating hormone α can 
inhibit cytokine-induced cutaneous inﬂ  ammation 
(Brazzini et al. 2003). Inﬂ  ammation also is a cru-
cial component in cardiovascular diseases, includ-
ing atherosclerosis. The autonomic nervous system 
may perform heart-brain communication through 
cytokine signaling to alter the disease course 
through anti-inﬂ  ammatory actions (Shishehbor, 42
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Alves, and Rajagopal, 2007). Neuropsychiatric 
disorders are inﬂ  uenced by neuroimmune interac-
tion via neurotransmitters and cytokines (Fricchione 
et al. 2001). Neuroendocrine-immune cross-talk is 
not limited to inﬂ  ammation as a triggering factor. 
Alcohol, for example, may serve as a neurochem-
ical regulator of the HPA axis (Haddad, 2004). 
Understanding this interaction should facilitate 
treatment of alcoholic addiction.
In short, research has advanced our understand-
ing of neuroimmune interaction in disease 
processes over the last decade. This new under-
standing has introduced a new approach to a vari-
ety of disease processes. Both pro-inﬂ  ammatory 
cytokines and immune cells have been targeted for 
the treatment of various diseases. With intensiﬁ  ed 
research, detailed underlying mechanisms will be 
revealed and innovative strategies will be devel-
oped to alter the course of currently debilitating 
and life threatening diseases.
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